Aly-Khan Lalani, MD of Dana Farber Cancer Institute discusses the integration of immunotherapies into renal cell carcinoma at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Aly-Khan Lalani, MD of Dana Farber Cancer Institute discusses the integration of immunotherapies into renal cell carcinoma at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.